REFERENCES
- Holmes C L, Patel B M, Russell J A, Walley K R. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989–1002, [INFOTRIEVE], [CSA]
- Malay M B, Ashton R C, Landry D W, Townsend R N. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47: 699–705, [INFOTRIEVE], [CSA]
- Patel B M, Chittock D R, Russell J A, Walley K R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576–582, [INFOTRIEVE], [CSA], [CROSSREF]
- Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487–493, [INFOTRIEVE], [CSA], [CROSSREF]
- Dellinger R P, Carlet J M, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–873, [INFOTRIEVE], [CSA], [CROSSREF]
- Morales D L, Gregg D, Helman D N, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69: 102–106, [INFOTRIEVE], [CSA], [CROSSREF]
- Morales D L, Garrido M J, Madigan J D, et al. A double-blind randomized trial: Prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003; 75: 926–930, [INFOTRIEVE], [CSA], [CROSSREF]
- Dünser M W, Mayr A J, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled Study. Circulation 2003; 107: 2313–2319, [CSA], [CROSSREF]
- Vanhoutte P M, Katusic Z S, Shepherd J T. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertens 1984; 2: S421–S422, [CSA]
- Landry D W, Oliver J A. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588–595, [INFOTRIEVE], [CSA], [CROSSREF]
- Parrillo J E, Parker M M, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113: 227–242, [INFOTRIEVE], [CSA]
- Sharshar T, Blanchard A, Paillard M, Raphael J C, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31: 1752–1758, [INFOTRIEVE], [CSA], [CROSSREF]
- Landry D W, Levin H R, Gallant E M, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122–1125, [INFOTRIEVE], [CSA]
- Brackett D J, Schaefer C F, Tompkins P, Fagraeus L, Peters L J, Wilson M F. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 1985; 17: 273–284, [INFOTRIEVE], [CSA]
- Wilson M F, Brackett D J, Hinshaw L B, Tompkins P, Archer L T, Behjamin B A. Vasopressin release during sepsis and septic shock in baboons and dogs. Surg Gynecol Obstet 1981; 153: 869–872, [INFOTRIEVE], [CSA]
- Wilson M F, Brackett D J, Tompkins P, Behjamin B, Archer L T, Hinshaw L B. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res 1981; 6: 15–26, [INFOTRIEVE], [CSA]
- Evora P R, Pearson P J, Schaff H V. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 1993; 103: 1241–1245, [INFOTRIEVE], [CSA]
- Wilson M F, Brackett D J, Archer L T, Hinshaw L B. Mechanisms of impaired cardiac function by vasopressin. Ann Surg 1980; 191: 494–500, [INFOTRIEVE], [CSA], [CROSSREF]
- Maturi M F, Martin S E, Markle D, et al. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation 1991; 83: 2111–2121, [INFOTRIEVE], [CSA]
- Bax W A, Van der Graaf P H, Stam W B, Bos E, Nisato D, Saxena P R. [Arg8]Vasopressin-induced responses of the human isolated coronary artery: Effects of non-peptide receptor antagonists. Eur J Pharmacol 1995; 285: 199–202, [INFOTRIEVE], [CSA], [CROSSREF]
- Fernández N, García J L, García-Villalón A L, Monge L, Gómez B, Diéguez G. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide. Eur J Pharmacol 1998; 324: 225–233, [CSA]
- Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens 1999; 17: 673–678, [INFOTRIEVE], [CSA], [CROSSREF]
- Katusic Z S, Shepherd J T, Vanhoutte P M. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res 1984; 55: 575–579, [INFOTRIEVE], [CSA]
- Sun Q, Dimopoulos G, Nguyen D N, et al. Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003; 168: 481–486, [INFOTRIEVE], [CSA], [CROSSREF]
- Guzman J A, Rosado A E, Kruse J A. Vasopressin vs norepinephrine in endotoxic shock: Systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol 2003; 95: 803–809, [INFOTRIEVE], [CSA]
- Edwards R M, Trizna W, Kinter L B. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989; 256: F274–F278, [INFOTRIEVE], [CSA]
- Edwards R M. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983; 244: F526–F534, [INFOTRIEVE], [CSA]
- Liard J F. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ Res 1986; 58: 631–640, [INFOTRIEVE], [CSA]
- Harrison-Bernard L M, Carmines P K. Juxtamedullary microvascular responses to arginine vasopressin in rat kidney. Am J Physiol 1994; 267: F249–F256, [INFOTRIEVE], [CSA]
- Bynum T E, Fara J W. Hepatic artery response to vasopressin. Am J Physiol 1980; 239: G378–G381, [INFOTRIEVE], [CSA]
- Martikainen T J, Tenhunen J J, Uusaro A, Ruokonen E. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003; 97: 1756–1763, [INFOTRIEVE], [CSA], [CROSSREF]